670 related articles for article (PubMed ID: 31875277)
1. Construction of an Inducible CRISPR/Cas9 System for CXCR4 Gene and Demonstration of its Effects on MKN-45 Cells.
Peng Y; Yang T; Tang X; Chen F; Wang S
Cell Biochem Biophys; 2020 Mar; 78(1):23-30. PubMed ID: 31875277
[TBL] [Abstract][Full Text] [Related]
2. Effects of HPV Pseudotype Virus in Cutting E6 Gene Selectively in SiHa Cells.
Cheng YX; Chen GT; Yang X; Wang YQ; Hong L
Curr Med Sci; 2018 Apr; 38(2):212-221. PubMed ID: 30074178
[TBL] [Abstract][Full Text] [Related]
3. Divergent susceptibilities to AAV-SaCas9-gRNA vector-mediated genome-editing in a single-cell-derived cell population.
Morsy SG; Tonne JM; Zhu Y; Lu B; Budzik K; Krempski JW; Ali SA; El-Feky MA; Ikeda Y
BMC Res Notes; 2017 Dec; 10(1):720. PubMed ID: 29221488
[TBL] [Abstract][Full Text] [Related]
4. Gene Therapy with CRISPR/Cas9 Coming to Age for HIV Cure.
Soriano V
AIDS Rev; 2017; 19(3):167-172. PubMed ID: 29019352
[TBL] [Abstract][Full Text] [Related]
5. An improved strategy for CRISPR/Cas9 gene knockout and subsequent wildtype and mutant gene rescue.
Jin J; Xu Y; Huo L; Ma L; Scott AW; Pizzi MP; Li Y; Wang Y; Yao X; Song S; Ajani JA
PLoS One; 2020; 15(2):e0228910. PubMed ID: 32053639
[TBL] [Abstract][Full Text] [Related]
6. Minimal 2'-O-methyl phosphorothioate linkage modification pattern of synthetic guide RNAs for increased stability and efficient CRISPR-Cas9 gene editing avoiding cellular toxicity.
Basila M; Kelley ML; Smith AVB
PLoS One; 2017; 12(11):e0188593. PubMed ID: 29176845
[TBL] [Abstract][Full Text] [Related]
7. Optimized Plasmid Construction Strategy for Cas9.
Xu J; Li W; Hossen MM; Jia Y; Li L; Huang Z
Cell Physiol Biochem; 2018; 48(1):131-137. PubMed ID: 30001549
[TBL] [Abstract][Full Text] [Related]
8. Highly multiplex guide RNA expression units of CRISPR/Cas9 were completely stable using cosmid amplification in a novel polygonal structure.
Nakanishi T; Maekawa A; Tabata H; Yoshioka T; Pei Z; Sato K; Mori M; Kato M; Saito I
J Gene Med; 2019 Nov; 21(11):e3115. PubMed ID: 31348845
[TBL] [Abstract][Full Text] [Related]
9. EasyGuide Plasmids Support in Vivo Assembly of gRNAs for CRISPR/Cas9 Applications in
Jacobus AP; Barreto JA; de Bem LS; Menegon YA; Fier Í; Bueno JGR; Dos Santos LV; Gross J
ACS Synth Biol; 2022 Nov; 11(11):3886-3891. PubMed ID: 36257021
[TBL] [Abstract][Full Text] [Related]
10. Simplified CRISPR-Mediated DNA Editing in Multicellular Eukaryotes.
Kumar R; Tiwari K; Saudagar P
Methods Mol Biol; 2023; 2575():241-260. PubMed ID: 36301478
[TBL] [Abstract][Full Text] [Related]
11. A lentivirus-based system for Cas9/gRNA expression and subsequent removal by Cre-mediated recombination.
Carpenter MA; Law EK; Serebrenik A; Brown WL; Harris RS
Methods; 2019 Mar; 156():79-84. PubMed ID: 30578845
[TBL] [Abstract][Full Text] [Related]
12. gRNA-transient expression system for simplified gRNA delivery in CRISPR/Cas9 genome editing.
Easmin F; Hassan N; Sasano Y; Ekino K; Taguchi H; Harashima S
J Biosci Bioeng; 2019 Sep; 128(3):373-378. PubMed ID: 31010727
[TBL] [Abstract][Full Text] [Related]
13. Doxycycline-Dependent Self-Inactivation of CRISPR-Cas9 to Temporally Regulate On- and Off-Target Editing.
Kelkar A; Zhu Y; Groth T; Stolfa G; Stablewski AB; Singhi N; Nemeth M; Neelamegham S
Mol Ther; 2020 Jan; 28(1):29-41. PubMed ID: 31601489
[TBL] [Abstract][Full Text] [Related]
14. Lipofection-mediated genome editing using DNA-free delivery of the Cas9/gRNA ribonucleoprotein into plant cells.
Liu W; Rudis MR; Cheplick MH; Millwood RJ; Yang JP; Ondzighi-Assoume CA; Montgomery GA; Burris KP; Mazarei M; Chesnut JD; Stewart CN
Plant Cell Rep; 2020 Feb; 39(2):245-257. PubMed ID: 31728703
[TBL] [Abstract][Full Text] [Related]
15. Two Distinct Approaches for CRISPR-Cas9-Mediated Gene Editing in Cryptococcus neoformans and Related Species.
Wang P
mSphere; 2018 Jun; 3(3):. PubMed ID: 29898980
[No Abstract] [Full Text] [Related]
16. Rapid and Efficient Gene Deletion by CRISPR/Cas9.
Neldeborg S; Lin L; Stougaard M; Luo Y
Methods Mol Biol; 2019; 1961():233-247. PubMed ID: 30912049
[TBL] [Abstract][Full Text] [Related]
17. Construction of Traf3 knockout liver cancer cell line using CRISPR/Cas9 system.
Hu W; Guo G; Chi Y; Li F
J Cell Biochem; 2019 Sep; 120(9):14908-14915. PubMed ID: 31016787
[TBL] [Abstract][Full Text] [Related]
18. [Establishment of Cas9 stably expressed human hepatocellular carcinoma and cholangiocarcinoma cell lines].
Zuo CX; Bian XC; Yang ZL; Feng HL; Zhou FY; Liu YQ
Zhonghua Zhong Liu Za Zhi; 2018 Aug; 40(8):572-579. PubMed ID: 30139026
[No Abstract] [Full Text] [Related]
19. Co-delivery of Cas9 mRNA and guide RNAs for editing of LGMN gene represses breast cancer cell metastasis.
Wang Y; Peng Y; Zi G; Chen J; Peng B
Sci Rep; 2024 Apr; 14(1):8095. PubMed ID: 38582932
[TBL] [Abstract][Full Text] [Related]
20. pCEC-red: a new vector for easier and faster CRISPR-Cas9 genome editing in Saccharomyces cerevisiae.
Maestroni L; Butti P; Senatore VG; Branduardi P
FEMS Yeast Res; 2023 Jan; 23():. PubMed ID: 36640150
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
